Efficacy of HA380 hemoperfusion in the treatment of septic shock
Open Access
- 14 August 2024
- journal article
- research article
- Published by Xia & He Publishing in Journal of Translational Critical Care Medicine
- Vol. 6 (3)
Abstract
Background: To evaluate the clinical efficacy of HA380 hemoperfusion (HP) in the treatment of septic shock. Methods: This study retrospectively analyzed the clinical data of patients with septic shock admitted to Ward II of the Department of Critical Care Medicine at the Shandong Provincial Hospital Affiliated to Shandong First Medical University from January 2022 to December 2023. These data included general information, temperature, heart rate (HR), mean arterial pressure (MAP), oxygenation index, norepinephrine (NE) dose, lactic acid, white blood cell count, neutrophil percentage, lymphocyte absolute value, procalcitonin (PCT), interleukin-6 (IL-6), acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA) before and after each blood perfusion (HA380), total hospital stay, intensive care unit (ICU) stay, and 28-day survival. Results: A total of 41 patients with septic shock were included in this study, consisting of 38 males and 3 females. According to their primary diseases, there were 18 cases of severe pneumonia, 16 cases of abdominal infection, 4 cases of bloodstream infection, 2 cases of urinary infection, and 1 case of soft tissue infection. At the time of inclusion, 33 patients underwent mechanical ventilation for respiratory support, and 4 patients were treated with extracorporeal membrane oxygenation. Statistically significant differences (all P < 0.05) were observed in body temperature, HR, MAP, oxygenation index, norepinephrine dose, lactic acid, PCT, IL-6, creatinine (Cr), APACHE II, and SOFA before and after HP (HA380) treatment. According to the 28-day survival status of patients, patients were allocated into survival and death groups. The total hospital stay and ICU stay were statistically significantly different between the two groups (all P < 0.05). Additionally, there were also statistically significant differences in APACHE II and SOFA before and after treatment (all P < 0.05). Based on the severity stratification of IL-6 and PCT levels, it was observed that following HP (HA380) treatment, all subgroups showed varying degrees of improvement in SOFA and APACHE II scores ( P < 0.05). Conclusion: HP (HA380) can improve the clinical efficacy of patients with septic shock. In addition, this method improves hemodynamics, effectively reduces lactic acid levels and infection indexes, and alleviates organ function damage in patients with septic shock, which can strive for more time for subsequent treatment.Keywords
This publication has 35 references indexed in Scilit:
- The pathogenesis and potential therapeutic targets in sepsisMedcomm, 2023
- Hemoperfusion in the intensive care unitIntensive Care Medicine, 2022
- Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysisIntensive Care Medicine, 2020
- Haemoperfusion with polymyxin B membrane: Recent results for an old debate!Anaesthesia Critical Care & Pain Medicine, 2019
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Endotoxin Elimination in Patients with Septic Shock: An Observation StudyArchivum Immunologiae et Therapiae Experimentalis, 2015
- High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trialIntensive Care Medicine, 2013
- Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill childrenIntensive Care Medicine, 2007
- High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shockIntensive Care Medicine, 2006
- The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre studyIntensive Care Medicine, 1999